Edible exosome-like nanoparticles from portulaca oleracea L mitigate DSS-induced colitis via facilitating double-positive CD4+CD8+T cells expansion
2023 · Journal of Nanobiotechnology · 132 citations
https://doi.org/10.1186/s12951-023-02065-0
D
Defeng Li
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
135
Papers
2.6K
Citations
27
h-index
61
i10-index
Defeng Li is an academic researcher from East China University of Science and Technology. The author has contributed to research in topics: Esophageal and GI Pathology & Gastric Cancer Management and Outcomes & Gastrointestinal Tumor Research and Treatment. The author has an h-index of 27, co-authored 115 publications.
ORCID: 0000-0003-3118-6840Papers by this author
worksTargeted therapy using engineered extracellular vesicles: principles and strategies for membrane modification
2023 · Journal of Nanobiotechnology · 124 citations
https://doi.org/10.1186/s12951-023-02081-0
Real-world of Limosilactobacillus reuteri in mitigation of acute experimental colitis
2025 · Journal of Nanobiotechnology · 16 citations
https://doi.org/10.1186/s12951-025-03158-8
TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis
2024 · Journal of Translational Medicine · 9 citations
https://doi.org/10.1186/s12967-023-04721-3
Noscapine derivative 428 suppresses ferroptosis through targeting GPX4
2025 · Redox Biology · 4 citations
https://doi.org/10.1016/j.redox.2025.103635
Clip-and-snare method with a pre-looping technique versus conventional method in the treatment of precancerous lesion and early gastric cancer: a retrospective study
2024 · BMC Gastroenterology · 3 citations
https://doi.org/10.1186/s12876-024-03231-w
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat